Article

Repurposing Ivermectin and ATRA as Potential Therapeutics for Glioblastoma Multiforme

2024-08-26

Abstract excerpt

<h4>Background</h4> Glioblastoma multiforme (GBM) is the most aggressive and lethal form of primary brain tumor, characterized by rapid growth and resistance to conventional therapies. Despite advances in treatment, most patients succumb to the disease within 15 months. Drug repurposing, which involves finding new uses for existing drugs, is a promising strategy to develop new GBM treatments faster and more cost-e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 12104c50-87d1-5823-a559-1407aa8217fc
DOI: 10.1101/2024.08.26.24312575

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Repurposing Ivermectin and ATRA as Potential Therapeutics for Glioblastoma MultiformeDOI 10.1101/2024.08.26.24312575Read

Reversal gene expression assessment for drug repurposing, a case study of glioblastomaSemantic proximity Read

Reversal Gene Expression Assessment for Drug Repurposing, a Case Study of GlioblastomaSemantic proximity Read

A multistep in silico approach identifies potential glioblastoma drug candidates via inclusive molecular targeting of glioblastoma stem cellsSemantic proximity Read

Repurposing of CNS accumulating drugs Gemfibrozil and Doxylamine for enhanced sensitization of glioblastoma cells through modulation of autophagySemantic proximity Read

BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screeningSemantic proximity Read

Differentially expressed genes in ethanol extract of vanilla planifolia stem-induced cell death in glioblastoma cellsSemantic proximity Read

A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.Semantic proximity Read

Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression dataSemantic proximity Read

A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem CellsSemantic proximity Read

Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing DisulfiramSemantic proximity Read

Non-oncology drugs are a source of previously unappreciated anti-cancer activitySemantic proximity Read

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideSemantic proximity Read